↓ Skip to main content

The Epigenome in Multiple Myeloma: Impact on Tumor Cell Plasticity and Drug Response

Overview of attention for article published in Frontiers in oncology, December 2018
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

twitter
4 X users

Citations

dimensions_citation
43 Dimensions

Readers on

mendeley
84 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Epigenome in Multiple Myeloma: Impact on Tumor Cell Plasticity and Drug Response
Published in
Frontiers in oncology, December 2018
DOI 10.3389/fonc.2018.00566
Pubmed ID
Authors

Eva De Smedt, Hui Lui, Ken Maes, Kim De Veirman, Eline Menu, Karin Vanderkerken, Elke De Bruyne

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 84 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 84 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 15 18%
Researcher 11 13%
Student > Bachelor 8 10%
Student > Doctoral Student 7 8%
Student > Master 6 7%
Other 12 14%
Unknown 25 30%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 21 25%
Medicine and Dentistry 13 15%
Agricultural and Biological Sciences 6 7%
Chemistry 3 4%
Immunology and Microbiology 3 4%
Other 7 8%
Unknown 31 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 January 2019.
All research outputs
#16,053,755
of 25,385,509 outputs
Outputs from Frontiers in oncology
#5,640
of 22,432 outputs
Outputs of similar age
#252,630
of 444,848 outputs
Outputs of similar age from Frontiers in oncology
#80
of 228 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,432 research outputs from this source. They receive a mean Attention Score of 3.0. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 444,848 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 228 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.